Results 211 to 220 of about 348,034 (261)
Engineering Organ-on-a-Chip Systems for Cancer Immunotherapy: Strategies and Assay Integration. [PDF]
Bioengineering (Basel)Wang J, Wang Z.
europepmc +1 more source
ELISPOT as a Functional for Biomarker Study in Cancer Immunotherapy: Applications and Future Directions. [PDF]
Int J Mol SciFernández Castro LR +5 more
europepmc +1 more source
Special Issue "Molecular Advances in Cancer Immunotherapy". [PDF]
Int J Mol SciSchaft N.
europepmc +1 more source
Hypoxic Tumor Microenvironment Targeting: Opportunities and Challenges for Pancreatic Cancer Immunotherapy. [PDF]
Int J Mol SciAbou Khouzam R +7 more
europepmc +1 more source
The Bitter Aftertaste of Artificial Sweeteners in Cancer Immunotherapy. [PDF]
Cancer DiscovChandra V, Li L, McAllister F.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Veterinary Clinics of North America: Small Animal Practice, 2009
The immune system is generally divided into 2 primary components: the innate immune response, and the highly specific but more slowly developing adaptive or acquired immune response. Immune responses can be further separated by whether they are induced by exposure to a foreign antigen (an "active" response) or whether they are transferred through serum
Constantin N, Baxevanis +2 more
+10 more sources
The immune system is generally divided into 2 primary components: the innate immune response, and the highly specific but more slowly developing adaptive or acquired immune response. Immune responses can be further separated by whether they are induced by exposure to a foreign antigen (an "active" response) or whether they are transferred through serum
Constantin N, Baxevanis +2 more
+10 more sources
Current Opinion in Immunology, 2013
The war on cancer began a little more than 40 years ago as a national research program to radically improve the survival of patients with cancer, a leading cause of death in the United States and worldwide. The main weapons deployed have been surgery, radiation, and chemotherapy, treatments that often carry risks and/or cause adverse side effects ...
KIM YOUNG JUN, PARDOLL DREW M, FU JUAN
+9 more sources
The war on cancer began a little more than 40 years ago as a national research program to radically improve the survival of patients with cancer, a leading cause of death in the United States and worldwide. The main weapons deployed have been surgery, radiation, and chemotherapy, treatments that often carry risks and/or cause adverse side effects ...
KIM YOUNG JUN, PARDOLL DREW M, FU JUAN
+9 more sources
Surgical Oncology Clinics of North America, 2011
Immune-based therapies for cancer are now commonplace. Cytokine therapy, including interferon and interleukin-2, is safe in the community setting. The US Food and Drug Administration has recently approved sipuleucel-T for the treatment of advanced prostate cancer, the first therapeutic cancer vaccine to meet this level of efficacy.
Richard L, White, Asim, Amin
openaire +4 more sources
Immune-based therapies for cancer are now commonplace. Cytokine therapy, including interferon and interleukin-2, is safe in the community setting. The US Food and Drug Administration has recently approved sipuleucel-T for the treatment of advanced prostate cancer, the first therapeutic cancer vaccine to meet this level of efficacy.
Richard L, White, Asim, Amin
openaire +4 more sources
Immunotherapy of cancer in 2012 [PDF]
Ca-A Cancer Journal for Clinicians, 2012 Abstract The immunotherapy of cancer has made significant strides in the past few years due to improved understanding of the underlying principles of tumor biology and immunology. These principles have been critical in the development of immunotherapy in the laboratory and in the implementation of immunotherapy in the clinic.
Ahmad Tarhini, Lisa H Butterfield
exaly +3 more sources